Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
not always cancer probable lyme disease mimicking squamous cell carcinoma a case report
Original title: “Not always cancer-Probable Lyme disease mimicking squamous cell carcinoma: A case report.”
The partners said the shot produced “clinically meaningful” efficacy despite missing its main study objective, a finding they blamed on a lower-than-expected rate of infections during the trial.
Original title: “Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results”
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne disease in a Phase 3 trial—but failed to hit a predetermined confidence interval.
Original title: “Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint”
The US sees around 476,000 new Lyme cases every year
Original title: “En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation”
A vaccine for Lyme disease is not currently available, clinical trials of new vaccines are underway.
Original title: “Lyme Disease Vaccine”
Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Original title: “HR 4981: Stamp Out Lyme Disease Act”
Tickborne diseases increasingly threaten the health of people in the United States. The growing threat includes newly discovered disease-causing germs, an increasing number of reported tickborne illnesses, expanding geographic ranges for ticks, and a novel tick species found in the US.
Original title: “Lyme and Other Tickborne Diseases Increasing”
Tickborne diseases are on the rise and prevention should be on everyone's mind, particularly during the spring, summer, and early-fall when ticks are most active.
Original title: “Lyme and other Tickborne Diseases”
The Centers for Disease Control and Prevention, in collaboration with Mayo Clinic and health officials from Minnesota, Wisconsin, and North Dakota, report the discovery of a new species of bacteria (Borrelia mayonii) that causes Lyme disease in people. Until now, Borrelia burgdorferi was the only species believed to cause Lyme disease in North America.
Original title: “New Lyme-disease-causing bacteria species discovered- Press Release”
Preliminary estimates released by the Centers for Disease Control and Prevention indicate that the number of Americans diagnosed with Lyme disease each year is around 300,000. The preliminary estimates were presented Sunday night in Boston at the 2013 International Conference on Lyme Borreliosis and Other Tick-Borne Diseases.
Original title: “CDC provides estimate of Americans diagnosed with Lyme disease each year - Press Release”
In recognition of Lyme Disease Awareness month, the Centers for Disease Control and Prevention reminds Americans to learn about this common tickborne disease and take steps to protect themselves if they live in or visit areas with Lyme disease activity.
Original title: “CDC Observes Lyme Disease Awareness Month”
Reported cases of Lyme disease have more than doubled since 1991, when Lyme became a nationally notifiable disease, according to a report by the Centers for Disease Control and Prevention (CDC). The report also said 93 percent of reported cases were concentrated in 10 states.
Original title: “CDC Reports High Lyme Disease Rates in 10 States Number of the most common vector-borne disease doubles in 15 years”